Methods comprising apoptosis inhibitors for the generation of transgenic pigs

Stem Cell Clinic
Patient Application
FAQ
Contact
Locations
News
Videos
Research
Patents
3D Culture/Scaffold
Administration
Differentiation
Expansion
Extraction/Preservation
Mobilization
Type
USE
 


Stem Cell Related Patent Number US7041870

Title:Transgenic transchromosomal rodents for making human antibodies
Inventors:Tomizuka, Kazuma; Takasaki, Japan
Ishida, Isao; Kanagawa, Japan
Lonberg, Nils; Woodside, CA, USA
Halk, Edward L.; Sunnyvale, CA, USA
Summary:This invention describes a new transgenic nonhuman mammal, comprising two human immunoglobulin loci. Specifically, described is a transgenic mouse wherein one of the human immunoglobulin loci is a human heavy chain locus, and the other locus is a human light chain locus, such that the human heavy chain locus is carried by transchromosome SC20 and the human light chain locus is carried by a transgene integrated into the genome of the mouse. Additionally, an endogenous mouse heavy chain locus and at least one endogenous mouse light chain locus are inactivated. Disclosed herein are the mechanisms by which such a novel transgenic mouse is capable of producing human sequence antibodies, and also discussed are various uses of these antibodies, such as in the generation of B cells expressing human sequence antibodies, and in the generation of antigen-specific hybridomas secreting human sequence antibodies.
Abstract:The present invention provides novel transgenic nonhuman mammals capable of producing human sequence antibodies, as well as methods of producing and using these antibodies.
US Patent Website:Click Here for Full Text of Patent
Title Number:US7041870
Application Number:US2001000000433
Date Filed:30/11/2001
Date Published:09/05/2006
Assignee:Medarex, Inc., Princeton, NJ, USA


 
Copyright © 2007 The Institute for Cellular Medicine  8/14/2020